Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line

Purpose: Drug resistance is a challenging issue in cancer chemotherapy. Cell death induction is one of the main strategies to overcome chemotherapy resistance. Notably, ferroptosis has been considered a critical cell death mechanism in recent years. Accordingly, in this study, the different cell dea...

Full description

Bibliographic Details
Main Authors: Morteza Golbashirzadeh, Hamid Reza Heidari, Mehdi Talebi, Ahmad Yari Khosroushahi
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2023-01-01
Series:Advanced Pharmaceutical Bulletin
Subjects:
Online Access:https://apb.tbzmed.ac.ir/PDF/apb-13-176.pdf
_version_ 1827806595390636032
author Morteza Golbashirzadeh
Hamid Reza Heidari
Mehdi Talebi
Ahmad Yari Khosroushahi
author_facet Morteza Golbashirzadeh
Hamid Reza Heidari
Mehdi Talebi
Ahmad Yari Khosroushahi
author_sort Morteza Golbashirzadeh
collection DOAJ
description Purpose: Drug resistance is a challenging issue in cancer chemotherapy. Cell death induction is one of the main strategies to overcome chemotherapy resistance. Notably, ferroptosis has been considered a critical cell death mechanism in recent years. Accordingly, in this study, the different cell death strategies focused on ferroptosis have been utilized to overcome cisplatin resistance in an in vitro lung cancer model. Methods: The physiological functions of Akt1 and GPX4, as critical targets for ferroptosis and apoptosis induction, were suppressed by siRNA or antagonistic agents in resistant A549 cells. Afterward, the interventions’ impacts on cell viability and reactive oxygen species (ROS) amount were analyzed by flow cytometry. Moreover, the alteration in the relevant gene and protein expression levels were quantified using Real-time PCR and western blot methods. Results: The result showed that the treatment with Akt1 siRNA reversed the cisplatin resistance in the A549 cell line through the induction of apoptosis. Likewise, the combination treatment of the GPX4 siRNA or FIN56 as ferroptosis inducers alongside cisplatin elevated ROS’s cellular level, reduced the cellular antioxidant genes level and increased the cisplatin cytotoxic effect. Conclusion: In conclusion, our study indicated that ferroptosis induction can be considered a promising cell death strategy in cisplatin-resistant cancer cells.
first_indexed 2024-03-11T21:44:18Z
format Article
id doaj.art-1fa5e78a19da4feba3200718c4a21f6d
institution Directory Open Access Journal
issn 2228-5881
2251-7308
language English
last_indexed 2024-03-11T21:44:18Z
publishDate 2023-01-01
publisher Tabriz University of Medical Sciences
record_format Article
series Advanced Pharmaceutical Bulletin
spelling doaj.art-1fa5e78a19da4feba3200718c4a21f6d2023-09-26T10:13:35ZengTabriz University of Medical SciencesAdvanced Pharmaceutical Bulletin2228-58812251-73082023-01-0113117618710.34172/apb.2023.019apb-32343Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell LineMorteza Golbashirzadeh0Hamid Reza Heidari1Mehdi Talebi2Ahmad Yari Khosroushahi3Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.Hematology and Oncology Research Center, Department of Applied Cell Sciences, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.Purpose: Drug resistance is a challenging issue in cancer chemotherapy. Cell death induction is one of the main strategies to overcome chemotherapy resistance. Notably, ferroptosis has been considered a critical cell death mechanism in recent years. Accordingly, in this study, the different cell death strategies focused on ferroptosis have been utilized to overcome cisplatin resistance in an in vitro lung cancer model. Methods: The physiological functions of Akt1 and GPX4, as critical targets for ferroptosis and apoptosis induction, were suppressed by siRNA or antagonistic agents in resistant A549 cells. Afterward, the interventions’ impacts on cell viability and reactive oxygen species (ROS) amount were analyzed by flow cytometry. Moreover, the alteration in the relevant gene and protein expression levels were quantified using Real-time PCR and western blot methods. Results: The result showed that the treatment with Akt1 siRNA reversed the cisplatin resistance in the A549 cell line through the induction of apoptosis. Likewise, the combination treatment of the GPX4 siRNA or FIN56 as ferroptosis inducers alongside cisplatin elevated ROS’s cellular level, reduced the cellular antioxidant genes level and increased the cisplatin cytotoxic effect. Conclusion: In conclusion, our study indicated that ferroptosis induction can be considered a promising cell death strategy in cisplatin-resistant cancer cells.https://apb.tbzmed.ac.ir/PDF/apb-13-176.pdfdrug resistancecisplatinapoptosisferroptosisgene silencing
spellingShingle Morteza Golbashirzadeh
Hamid Reza Heidari
Mehdi Talebi
Ahmad Yari Khosroushahi
Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line
Advanced Pharmaceutical Bulletin
drug resistance
cisplatin
apoptosis
ferroptosis
gene silencing
title Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line
title_full Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line
title_fullStr Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line
title_full_unstemmed Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line
title_short Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line
title_sort ferroptosis as a potential cell death mechanism against cisplatin resistant lung cancer cell line
topic drug resistance
cisplatin
apoptosis
ferroptosis
gene silencing
url https://apb.tbzmed.ac.ir/PDF/apb-13-176.pdf
work_keys_str_mv AT mortezagolbashirzadeh ferroptosisasapotentialcelldeathmechanismagainstcisplatinresistantlungcancercellline
AT hamidrezaheidari ferroptosisasapotentialcelldeathmechanismagainstcisplatinresistantlungcancercellline
AT mehditalebi ferroptosisasapotentialcelldeathmechanismagainstcisplatinresistantlungcancercellline
AT ahmadyarikhosroushahi ferroptosisasapotentialcelldeathmechanismagainstcisplatinresistantlungcancercellline